H20020010 | 拉莫三嗪片 | lamotrigine | Tablet | Chemical Drugs | Import Drug Application | 2002-02-26 | 葛兰素史克(中国)投资有限公司北京办事处 | Glaxosmithkline China Beijing | Approval Completed-Pending Certificated | | view |
H20020286 | 阿昔洛韦软膏 | aciclovir | Ointment | Chemical Drugs | Import Drug Application | 2002-11-22 | 葛兰素史克(中国)投资有限公司北京办事处 | Glaxosmithkline China Beijing | Approval Completed-Pending Certificated | | view |
JYHB1000961 | 硫酸阿巴卡韦片 | abacavir sulfate | Tablet | Chemical Drugs | Supplementary Application | 2010-11-11 | 葛兰素史克(中国)投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;Viiv Healthcare Uk Ltd;Glaxo Wellcome Operations | Certificate Issued | 2011-05-25 | view |
H20020182 | 丙酸氟替卡松乳膏 | fluticasone propionate | Cream | Chemical Drugs | Import Drug Application | 2002-07-25 | 葛兰素史克(中国)投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd | Approval Completed-Pending Certificated | | view |
JYHB1400159 | 沙美特罗替卡松气雾剂 | fluticasone propionate;salmeterol xinafoate | Aerosol | Chemical Drugs | Supplementary Application | 2014-02-13 | 葛兰素史克(中国)投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;Glaxo Smithkline Australia Pty Ltd;Glaxo Wellcome Production | Certificate Issued | 2019-03-29 | view |
JYHZ1900158 | 沙美特罗替卡松吸入气雾剂 | fluticasone propionate;salmeterol xinafoate | Aerosol | Chemical Drugs | License Renew | 2019-07-01 | 葛兰素史克(中国)投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;Glaxo Smithkline Australia Pty Ltd;Glaxo Wellcome Production | Certificate Issued | 2019-11-25 | view |
JYHB2001841 | 多替拉韦钠片 | | Tablet | Chemical Drugs | Supplementary Application | 2020-09-22 | 葛兰素史克(中国)投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;Viiv Healthcare BV;Glaxo Operations UK Ltd | Filed | 2020-10-12 | view |
JYHB1401300 | 那屈肝素钙注射液 | nadroparin calcium | Injection | Chemical Drugs | Supplementary Application | 2014-09-22 | 葛兰素史克(中国)投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;Laboratoire Glaxosmithkline;Glaxo Wellcome Production | Certificate Issued | 2015-12-11 | view |
JXHL1700016 | Daprodustat片 | daprodustat | Tablet | Chemical Drugs(1) | Import Drug Application | 2017-02-20 | 葛兰素史克(中国)投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;GlaxoSmithKline Research & Development Ltd | Certificate Issued | 2017-07-26 | view |
JXHL1000011 | 盐酸安非他酮缓释片 | bupropion hydrochloride | Tablet, extended release | Chemical Drugs | Import Drug Application | 2010-02-21 | 葛兰素史克(中国)投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;Glaxosmithkline Gmbh & Co KG | Certificate Issued | 2013-10-21 | view |
H20010150 | 拉米夫定原料 | lamivudine | Active ingredient | Chemical Drugs | Import Drug Application | 2001-06-20 | 葛兰素史克(中国)投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd | Approval Completed-Pending Certificated | | view |
JYHB1301508 | 硫酸沙丁胺醇气雾剂 | salbutamol sulfate | Aerosol | Chemical Drugs | Supplementary Application | 2013-12-02 | 葛兰素史克(中国)投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;Glaxo Smithkline Australia Pty Ltd;Glaxo Wellcome SA | Certificate Issued | 2015-05-12 | view |
JYSB1800297 | 重组乙型肝炎疫苗(酿酒酵母) | Recombinant Hepatitis B Vaccine(Saccharomyces cerevisiae) | Injection | Biological Products | Supplementary Application | 2018-12-25 | 葛兰素史克(中国)投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;GlaxoSmithKline Biologicals SA | Certificate Issued | 2020-01-02 | view |
JYHB2001437 | 拉莫三嗪分散片 | lamotrigine | Tablet | Chemical Drugs | Supplementary Application | 2020-08-21 | 葛兰素史克(中国)投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;The Wellcome Foundation Ltd;GlaxoSmithKline Phaemaceuticals SA | Filed | 2020-09-02 | view |
JYHB0601103 | 米库氯铵注射液 | mivacurium chloride | Injection | Chemical Drugs | Supplementary Application | 2006-12-28 | 葛兰素史克(中国)投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;The Wellcome Foundation Ltd;GlaxoSmithKline Manufacturing SpA | Certificate Issued | 2008-10-09 | view |
JYHB1400719 | 阿莫西林克拉维酸钾干混悬剂 | amoxicillin;potassium clavulanate | Suspension | Chemical Drugs | Supplementary Application | 2014-06-10 | 葛兰素史克(中国)投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;Smithkline Beecham Ltd | Certificate Issued | 2015-12-17 | view |
JYSB1600147 | 重组乙型肝炎疫苗(酿酒酵母) | Recombinant Hepatitis B Vaccine(Saccharomyces cerevisiae) | Injection | Biological Products | Supplementary Application | 2016-08-11 | 葛兰素史克(中国)投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;GlaxoSmithKline Biologicals SA | Certificate Issued | 2017-12-20 | view |
JYHZ2000175 | 多替拉韦钠片 | | Tablet | Chemical Drugs | License Renew | 2020-07-11 | 葛兰素史克(中国)投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;Viiv Healthcare BV;Glaxo Operations UK Ltd | Certificate Issued | 2020-12-22 | view |
JXHL0700413 | 磺达肝癸钠注射液 | fondaparinux sodium | Injection | Chemical Drugs(3.1) | Import Drug Application | 2007-12-26 | 葛兰素史克(中国)投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;Glaxo Group Ltd | Certificate Issued | 2009-09-08 | view |
JYHB2100027 | 丙酸氟替卡松吸入气雾剂 | fluticasone propionate | Aerosol | Chemical Drugs | Supplementary Application | 2021-01-08 | 葛兰素史克(中国)投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;Glaxo Smithkline Australia Pty Ltd;Glaxo Wellcome SA | In Review | 2021-01-07 | view |